Product Categories
| Country: | China |
|---|---|
| Tel: | 180-04525530 |
| Mobile: | 18004525530 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| SARS-CoV-2 Spike receptor binding domain, RBD (336-347) - Lys(Biotin-LC) - 0.1 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (348-357)- Lys(Biotin-LC) - 0.1 mg | Details |
| Proapoptotic Peptide, (klaklak)2, 5-FAM-labeled - 1 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (523-541) - 0.5 mg | Details |
| pp60(v-SRC) Autophosphorylation Site, Phosphorylated - 1 mg | Details |
| QXL? 490 acid - 10 mg | Details |
| Proinsulin C-peptide (55-87), porcine - 0.5 mg | C142H239N47O46 | 28152-90-1 | Details |
| Protease-Activated Receptor-3, PAR-3 Agonist, amide - 1 mg | C25H36N8O8 | 261521-21-5 | Details |
| Pyrrhocoricin - 1 mg | C113H179N33O34 | 156548-23-1 | Details |
| Protein A-HiLyte Fluor 555 Conjugate - 1 mg | Details |
| SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 - 0.5 mg | Details |
| Prostatic Acid Phosphatase (248-286), PAP (248-286) - 1 mg | Details |
| Protein A-HiLyte Fluor 488 Conjugate - 1 mg | Details |
| Protein A-HiLyte Fluor 750 Conjugate - 1 mg | Details |
| Protein A-Biotin Conjugate - 5 mg | Details |
| QXL? 570 C2 maleimide - 5 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (352-365) - Lys(Biotin-LC) - 0.1 mg | Details |
| Protease-Activated Receptor-1, PAR-1 Agonist 2, amide - 1 mg | Details |
| Protease-Activated Receptor-3, PAR-3 (1-6), human - 1 mg | C29H46N10O7 | 1872435-09-0 | Details |
| Protease-Activated Receptor-2, PAR-2 Agonist, amide - 1 mg | C36H63N11O8 | 729589-58-6 | Details |
| Rat Renin, recombinant - 20 μg | Details |
| SARS-CoV Peptide Antigen Negative control - 1mg NET peptide | Details |
| RGD-4C - 5 mg | Details |
| S6 Kinase Substrate (229-239), Amide, Biotinalyted - 1 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (513-520) - 0.5 mg | Details |
| Prosaptide TX14(A) | C69H110N16O26 | 196391-82-9 | Details |
| S6 Kinase Substrate (229-239) | C54H104N24O14 | Details |
| PrP (106-126), prion protein - 1 mg | C80H138N26O24S2 | 148439-49-0 | Details |
| Pluronic? F-127 Cell Culture Tested - 10 g | (C3H6O.C2H4O)x | 9003-11-6 | Details |
| SAMS Peptide [HMRSAMSGLHLVKRR-NH2] - 5 mg | Details |
| PSTi8, 1mg | Details |
| pro-NPY peptide (34-43), human - 0.1 mg | Details |
| Quinine sulfate Fluorescence Reference Standard - 100 mg | C20H26N2O6S | 6119-70-6 | Details |
| Resorufin -D-Galactopyranoside - 25 mg | C18H17NO8 | 95079-19-9 | Details |
| R-PE (R-Phycoerythrin) - 1 mg | Details |
| Renin Inhibitor Peptide, WFML Peptide, rat - 1 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (371-394) - Lys(Biotin-LC) - 0.1 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (336-347) - 0.5 mg | Details |
| Protein A-HiLyte Fluor 647 Conjugate - 1 mg | Details |
| RS domain derived peptide - 1 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (319-335) -Lys(Biotin-LC) - 0.1 mg | Details |
| Proadrenomedullin N-term peptide, PAMP (1-20) - 5 mg | C112H178N36O27 | 150238-87-2 | Details |
| Renin Substrate, Angiotensinogen (1-14), human - 1 mg | C83H122N24O19 | 104180-23-6 | Details |
| Pramlintide, Acetate [Pro25, 28, 29]-Amylin(1-37), human, Amide - 1 mg | C173H273N51O56S2 | 196078-30-5 | Details |
| QXL? 570 acid, SE - 5 mg | Details |
| SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458 - 0.5 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (395-430) - Lys(Biotin-LC) - 0.1 mg | Details |
| Protease-Activated Receptor-1, PAR-1 Agonist - 1 mg | Details |
| Proapoptotic Peptide, (klaklak)2 - 1 mg | Details |
| Renin Substrate, Angiotensinogen (1-14), rat - 1 mg | C89H123N21O21 | 110200-37-8 | Details |
| QXL? 670 acid, SE - 5 mg | Details |
| pVEC (Cadherin-5) - 1 mg | Details |
| PUMA BH3 - 1 mg | Details |
| Pluronic? F-127, 20 % solution in DMSO - 10 ml | Details |
| Ryanodine receptor 1 (RyR1) (3614-3643), Calmodulin Binding Peptide (CaMBP) - 1 mg | Details |
| Recombinant human MOG (1-125) | Details |
| Protease-Activated Receptor-4, PAR-4 Agonist 3, amide, murine - 1 mg | C33H46N8O7 | 245443-52-1 | Details |
| SAMs peptide, FAM labeled - 1 mg | Details |
| SARS-CoV Peptide Antigen Positive control - 1mg NET peptide | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (523-541) - Lys(Biotin-LC) - 0.1 mg | Details |
| Protease-Activated Receptor-1, PAR-1 Agonist 1, amide - 5 mg | Details |
| Protease-Activated Receptor-1, PAR-1 Antagonist 1 - 1 mg | C45H67N11O10 | 149440-16-4 | Details |
| Rhod-2, AM UltraPure Grade - 1 mg | C52H59N4O19.Br | 145037-81-6 | Details |
| Protease-Activated Receptor-2, PAR-2 Agonist 2, amide - 5 mg | C28H54N8O7 | 190383-13-2 | Details |
| Recombinant rat MOG (1-125) | Details |
| Protease-Activated Receptor-1, PAR-1 Agonist 3, amide - 1 mg | Details |
| SARS-CoV Peptide Antigen I - 1mg NET peptide | Details |
| Proteases Substrate, Fluorogenic, (Z-R)2Rh1102HCl - 5 mg | Details |
| Poly-gamma-D-Glutamic Acid Construct - 1 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (371-394) - 0.5 mg | Details |
| QXL? 490 acid, SE - 5 mg | Details |
| S3 Fragment, ADF/cofilin, LIMK1 substrate - 1 mg | Details |
| Propidium iodide, 1.0 mg/mL solution in water - 10 ml | C27H34IN4+ | 25535-16-4 | Details |
| Prodan [6-Propionyl-2-dimethylaminonaphthalene] - 25 mg | C15H17NO | 70504-01-7 | Details |
| RGDS - 5 mg | C15H27N7O8 | 91037-65-9 | Details |
| Protease-Activated Receptor-1, PAR-1 Antagonist 2, amide - 1 mg | Details |
| QXL? 570 acid - 10 mg | Details |
| Renin FRET Substrate (5-FAM/QXL? 520), rat - 0.1 mg | Details |
| Rhodopsin Epitope Tag - 5 mg | Details |
| Protease-Activated Receptor-4, PAR-4 Agonist, amide | C34H48N8O7 | 352017-71-1 | Details |
| PMAP-23 | Details |
| Proinsulin C-peptide (55-89), human - 0.5 mg | C153H259N49O52 | 11097-48-6 | Details |
| Protease-Activated Receptor-4, PAR-4 Antagonist, amide - 1 mg | C40H49N7O7 | 327177-34-4 | Details |
| Renin FRET Substrate, R-E(EDANS)--K(Dabcyl) - 1 mg | C109H156N32O21S | 791068-69-4 | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (352-365) - 0.5 mg | Details |
| SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 - 0.5 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (319-335) - 0.5 mg | Details |
| RH414 - 5 mg | C28H43Br2N3 | 161433-30-3 | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (395-430) - 0.5 mg | Details |
| SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 - 0.5 mg | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (348-357) - 0.5 mg | Details |
| Pluronic? F-127, 10 % solution in water - 100 ml | Details |
| Renin FRET Substrate (5-FAM/QXL? 520) - 0.1 mg | Details |
| SARS-CoV T-cell Peptide Antigens Set - 0.25 mg Net | Details |
| SARS-CoV-2 Spike receptor binding domain, RBD (513-520) - Lys(Biotin-LC) - 0.1 mg | Details |
| Renin FRET substrate, Dabcyl/EDANS - 1 mg | C90H120N22O16S | 142988-22-5 | Details |
| Recombinant mouse MOG (1-125) | Details |
| Rabies Virus Glycoprotein (RVG) - 1 mg | Details |
| Rev4 | Details |
| Protegrin-1 (PG-1), amide | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 | ||||